Cost-effective analysis of low- versus high-dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia - PubMed (original) (raw)

Comparative Study

Cost-effective analysis of low- versus high-dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia

Lama H Nazer et al. Int J Clin Pharm. 2019 Feb.

No abstract available

PubMed Disclaimer

References

    1. Clin Infect Dis. 2016 Mar 1;62(5):552-558 -PubMed
    1. Am J Health Syst Pharm. 2017 Jan 1;74(1):e9-e16 -PubMed
    1. Clin Infect Dis. 2016 Dec 23;64(5):565-571 -PubMed
    1. Int J Clin Pharm. 2018 Oct;40(5):1051-1058 -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources